Earnings
Home›Earnings›Previews›Small-caps highlight Ascentage Pharma, Maze Therapeuti…
Small-caps highlight Ascentage Pharma, Maze Therapeutics, Pagaya catalysts
The three names are described as having improving fundamentals and strong cash positions, backed by bullish analyst ratings.
MarketBeat Ratings highlights three small-cap companies, Ascentage Pharma, Maze Therapeutics, and Pagaya Technologies, saying each has catalysts that could attract more investor attention as the market looks beyond mega-cap tech.
The outlet points to improving fundamentals, unique business models, and strong cash positions, alongside bullish analyst ratings, as reasons these stocks could stand out.
The piece also notes that rising interest rates may create an opening for contrarian investors to buy smaller companies before financing conditions improve.
It cautions that small-caps still face risks such as volatility, operational concerns, and cash flow issues, even with the identified catalysts.